HeartCycle Project Sets Out to Create Innovative Telemonitoring Solutions

Clothes, bed sheets and home appliances could soon help heart patients to better deal with their condition. The new EU-funded HeartCycle project sets out to create innovative telemonitoring solutions. Launched on 1 March, it is one of the largest biomedical and healthcare research projects in the EU.

The system that the industry-led research consortium is planning to develop will improve the quality of care for coronary heart disease and heart failure patients by monitoring their condition at home, using unobtrusive sensors built into everyday objects. At the same time, the system is intended to report automatically to clinicians, so that they can adapt therapies and make lifestyle recommendations, as well as involve the patients themselves in the management of their disease. The latter is a great challenge as well as a great opportunity, according to Professor John Cleland, head of the Department of Cardiology at the University of Hull, UK. "Investing directly in people who need help, and not just in services that do things to or for them, makes sense in terms of improved care, greater affordability and the effective deployment of scarce nursing and medical resources," he says.

"By developing systems that remotely monitor heart patients and motivate them to adhere to treatment regimes and adopt beneficial lifestyles, we hope to improve the survival of people with heart disease as well as contain the overall cost of care," explains Henk van Houten, senior vice president of Phillips Research and head of the Healthcare Research programme.

"The development of such systems can only be achieved efficiently via multi-disciplinary partnerships between hardware engineers, software engineers, textile manufacturers, industrial designers, clinical experts and healthcare providers, as is the case in the HeartCycle project," Mr van Houten adds.

The public and private 18 project partners from Germany, Greece, Finland, Spain, Portugal, the Netherlands, the UK, Italy, Switzerland and China come from numerous different backgrounds in research, academia, medicine and industry. Over a period of four years, the EU will invest more than €14 million in the HeartCycle research under its Seventh Framework Programme (FP7). The total project cost amounts to nearly €22 million.

HeartCycle builds on the progress made by the MyHeart project, which will end in December 2008 and received funding under the Information Society Technologies (IST) programme of the Sixth Framework Programme (FP6). MyHeart, bringing together some of the same actors, developed advanced telemonitoring technologies and service concepts to enable people to play an active role in maintaining their health. It was during this research that the project partners identified home-based disease management as a potential field for improving medical standards of care, an objective that HeartCycle is trying to achieve with a focus on coronary heart disease.

A total of 1.9 million deaths in the EU every year are the result of cardiovascular diseases, causing annual health costs of €105 billion. Half of those deaths occur in people who have previously had a heart attack, which is why the project partners consider "finding better ways to manage and treat coronary heart disease and chronic heart failure as one of the most effective ways of reducing the human cost and financial burden of these debilitating conditions."

For further information, please visit:
http://www.research.philips.com/

Related news articles:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...